Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013

International Journal of Antimicrobial Agents

Volumn 47, Issue 4, 2016, Pages 328-334

  Jean, Shio Shin ^a,b   Coombs, Geoffrey ^c   Ling, Thomas ^d   Balaji, V ^e   Rodrigues, Camilla ^f   Mikamo, Hiroshige ^g   Kim, Min Ja ^h   Rajasekaram, Datin Ganeswrie ⁱ   Mendoza, Myrna ^j   Tan, Thean Yen ^k   Kiratisin, Pattarachai ^l   Ni, Yuxing ^m   Weinman, Barry ⁿ   Xu, Yingchun ^o   Hsueh, Po Ren ^p  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c ROYAL PERTH HOSPITAL   (Australia)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e CHRISTIAN MEDICAL COLLEGE   (India)

^f P D HINDUJA NATIONAL HOSPITAL   (India)

^g AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^h College of Medicine   (South Korea)

ⁱ HOSPITAL SULTANAH AMINAH   (Malaysia)

^j PHILIPPINE GENERAL HOSPITAL   (Philippines)

^k CHANGI GENERAL HOSPITAL   (Singapore)

^l MAHIDOL UNIVERSITY   (Thailand)

^m SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

ⁿ MERCK RESEARCH LABORATORIES   (United States)

^o PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^p NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

more..

Author keywords

ESBL; Extended spectrum lactamase; Gram negative bacteria; Hospital acquired; Susceptibility; Urinary tract infection

Indexed keywords

AMIKACIN; BETA LACTAM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; AUSTRALIA; BACTERIAL STRAIN; CHINA; CONTROLLED STUDY; DRUG MONITORING; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; EPIDEMIOLOGY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HONG KONG; HUMAN; IN VITRO STUDY; INDIA; JAPAN; KAZAKHSTAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALAYSIA; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NEW ZEALAND; PHILIPPINES; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SINGAPORE; SOUTH KOREA; TAIWAN; THAILAND; URINARY TRACT INFECTION; VIET NAM; AUSTRALIA AND NEW ZEALAND; CROSS INFECTION; DRUG EFFECTS; ENZYMOLOGY; GRAM-NEGATIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; URINARY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; ASIA; AUSTRALASIA; BETA-LACTAMASES; CROSS INFECTION; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; URINARY TRACT INFECTIONS;

EID: 84961218721     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.01.008     Document Type: Article

References (17)

1. P.R. Hsueh, D.J. Hoban, Y. Carmeli, S.Y. Chen, S. Desikan, M. Alejandria, and et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region J Infect 63 2011 114 123
2. D.A. Talan, A. Krishnadasan, F.M. Abrahamian, W.E. Stamm, G.J. Moran EMERGEncy ID NET Study Group Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis Clin Infect Dis 47 2008 1150 1158
3. F. Perez, A. Endimiani, K.M. Hujer, and R.A. Bonomo The continuing challenge of ESBLs Curr Opin Pharmacol 7 2007 459 469
4. C.H. Kung, W.W. Ku, C.H. Lee, C.P. Fung, S.C. Kuo, T.L. Chen, and et al. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study J Microbiol Immunol Infect 48 2015 168 174
5. P.L. Lu, Y.C. Liu, H.S. Toh, Y.L. Lee, Y.M. Liu, C.M. Ho, and et al. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Int J Antimicrob Agents 40 Suppl 2012 S37 S43
6. M.Y. Lee, H.J. Choi, J.Y. Choi, M. Song, Y. Song, S.W. Kim, and et al. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea J Infect 60 2010 146 153
7. Y.C. Lin, W.H. Sheng, S.C. Chang, J.T. Wang, Y.C. Chen, R.J. Wu, and et al. Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities J Clin Microbiol 46 2008 612 617
8. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement Document M100-S25 2015 CLSI Wayne, PA
9. S.S. Jean, and P.R. Hsueh High burden of antimicrobial resistance in Asia Int J Antimicrob Agents 37 2011 291 295
10. S.P. Hawser, S.K. Bouchillon, D.J. Hoban, R.E. Badal, P.R. Hsueh, and D.L. Paterson Emergence of high levels of extended-spectrum-β-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007 Antimicrob Agents Chemother 53 2009 3280 3284
11. R. Moayednia, D. Shokri, S. Mobasherizadeh, A. Baradaran, S.M. Fatemi, and A. Merrikhi Frequency assessment of β-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection J Res Med Sci 19 Suppl 1 2014 S41 S45
12. S. Bouchillon, D.J. Hoban, R. Badal, and S. Hawser Fluoroquinolone resistance among Gram-negative urinary tract pathogens: Global Smart Program Results, 2009-2010 Open Microbiol J 6 2012 74 78
13. K. Lee, M. Lee, J.H. Shin, M.H. Lee, S.H. Kang, A.J. Park, and et al. Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea Microb Drug Resist 12 2006 44 49
14. S.H. Park, S.M. Choi, Y.K. Chang, D.G. Lee, S.Y. Cho, H.J. Lee, and et al. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli J Antimicrob Chemother 69 2014 2848 2856
15. C. Bin, W. Hui, Z. Renyuan, N. Yongzhong, X. Xiuli, X. Yingchun, and et al. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli Diagn Microbiol Infect Dis 56 2006 351 357
16. S.S. Jean, W.S. Lee, K.W. Yu, C.H. Liao, C.W. Hsu, F.Y. Chang, and et al. Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) J Microbiol Immunol Infect 2015 10.1016/j.jmii.2014.12.008 [Epub ahead of print]
17. S.S. Jean, P.R. Hsueh, W.S. Lee, K.W. Yu, C.H. Liao, F.Y. Chang, and et al. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009 Int J Antimicrob Agents 41 2013 457 462